; (B) capacity building; (C) strengthening human health surveillance systems for emergence of zoonotic disease, and strengthening cross-sectoral collaboration to align risk reduction approaches; (D) improved domestic and wild animal disease surveillance and control at production and market levels; (E) development of alternative livelihood opportunities where possible; (F) conservation of intact ecosystems and reduction of fragmentation and conversion of natural habitats to prevent the creation of new pathways for zoonotic disease transmission; (G) minimizing interactions between domestic livestock and wild animals in markets and captive production